AgingResearch.NewsJoin free

BIOIO-1001

Intervention

1 paper studies it3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: National Institute of Diabetes and Digestive and Kidney Diseases and 2 more
  • 3 of 3 findings with company ties
  • Animals1

Outcomes

3

Amyotrophic lateral sclerosis

downin animals1

1 study

  1. BIOIO-1001 protects against amyotrophic lateral sclerosis.

    “BIOIO-1001 was protective in both sporadic and familial ALS models”

    Animalsin both sporadic and familial ALS models

    A DUAL MTOR/NAD+ ACTING GEROTHERAPY

    bioRxiv : the preprint server for biologyPreprint

More on Amyotrophic lateral sclerosis

Fibrosis

downin animals1

1 study

  1. BIOIO-1001 decreases fibrosis.

    “BIOIO-1001 reduced high fat, high sugar diet-induced metabolic derangements, inflammation, and fibrosis”

    Animalshigh fat, high sugar diet-induced

    A DUAL MTOR/NAD+ ACTING GEROTHERAPY

    bioRxiv : the preprint server for biologyPreprint

Inflammation

downin animals1

1 study

  1. BIOIO-1001 decreases inflammation.

    “BIOIO-1001 reduced high fat, high sugar diet-induced metabolic derangements, inflammation, and fibrosis”

    Animalshigh fat, high sugar diet-induced

    A DUAL MTOR/NAD+ ACTING GEROTHERAPY

    bioRxiv : the preprint server for biologyPreprint

More on Inflammation

Latest

Related